ReviR Therapeutics to Present at RNA Targeted Drug Discovery Summit
- Written by PR Newswire
SAN FRANCISCO, Calif., Dec. 8, 2022 /PRNewswire/ -- ReviR Therapeutics (ReviR), a biotechnology company developing small molecule therapies targeting RNA, today announced an upcoming presentation at the 5th Annual RNA Targeted Drug Discovery conference taking place December 13-15, 2022 in Boston, MA.
Title: Defining Disease-specific RNA...
Read more: ReviR Therapeutics to Present at RNA Targeted Drug Discovery Summit














